Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker TNET
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Oct 29, 2026 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 14, 2026 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 30, 2026 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 17, 2026 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 27, 2026 | TNET TriNet Group, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 30, 2026 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 19, 2026 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 12, 2026 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 11, 2025 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2025 | TNET TriNet Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 29, 2025 | TNET TriNet Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2025 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 30, 2025 | TNET TriNet Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 17, 2025 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 25, 2025 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 12, 2025 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 27, 2025 | TNET TriNet Group, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 25, 2025 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 20, 2025 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2025 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 12, 2024 | TNET TriNet Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 25, 2024 | TNET TriNet Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
22 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 3:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances